Burning Rock Biotech (Burning Rock Biotech) Price-to-Tangible-Book : 0.74 (As of Apr. 28, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Price-to-Tangible-Book?

As of today (2024-04-28), Burning Rock Biotech's share price is $0.85. Burning Rock Biotech's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was $1.15. Hence, Burning Rock Biotech's Price to Tangible Book Ratio of today is 0.74.

The historical rank and industry rank for Burning Rock Biotech's Price-to-Tangible-Book or its related term are showing as below:

BNR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.74 Med: 3.62 Max: 9.13
Current: 0.74

During the past 6 years, Burning Rock Biotech's highest Price to Tangible Book Ratio was 9.13. The lowest was 0.74. And the median was 3.62.

BNR's Price-to-Tangible-Book is ranked better than
86.39% of 169 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.4 vs BNR: 0.74

A closely related ratio is called PB Ratio. As of today, Burning Rock Biotech's share price is $0.85. Burning Rock Biotech's Book Value per Sharefor the quarter that ended in Sep. 2023 was $1.16. Hence, Burning Rock Biotech's P/B Ratio of today is 0.74.

Burning Rock Biotech Price-to-Tangible-Book Historical Data

The historical data trend for Burning Rock Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Price-to-Tangible-Book Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

Get a 7-Day Free Trial

6.53

3.47

1.39

Burning Rock Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.36	1.39	1.91	1.64	0.84

Competitive Comparison of Burning Rock Biotech's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Burning Rock Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burning Rock Biotech's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Burning Rock Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Burning Rock Biotech's Price-to-Tangible-Book falls into.

Burning Rock Biotech Price-to-Tangible-Book Calculation

Burning Rock Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	0.85	/	1.154
	=	0.74

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Burning Rock Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.